TGTX Stock Analysis: Buy, Sell, or Hold?
TGTX - TG Therapeutics, Inc.
$31.48
-0.27 (-0.87%)
▼
5d:
+3.37%
30d:
+4.6%
90d:
+2.29%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 04, 2026
Smart Money Accumulation
TGTX is down 3.9% this week, but smart money is accumulating calls. Top strike: $35 2026-05-15 with 1,028 OI. Call ratio: 72% View Scanner →
Strength: 4.1/10
Get Alerted When TGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TGTX shows positive signals but monitor for confirmation. Market pricing in 6.3% decline. Moderate conviction.
💡 BUY OPPORTUNITY: TGTX shows positive signals but monitor for confirmation. Market pricing in 6.3% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$75.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$46.75
32.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TGTX is currently trading at $31.48, which is considered extended relative to its 30-day fair value range of $28.61 to $30.92. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.9) compared to its historical average (15.7). Remarkably, the market is currently pricing in an annual earnings decline of 6.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TGTX is in a downtrend. Immediate support is located at $28.61, while resistance sits at $32.47.
Market Sentiment: TGTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $44.43 (+39.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TGTX is in a downtrend. Immediate support is located at $28.61, while resistance sits at $32.47.
Market Sentiment: TGTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $44.43 (+39.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$28.61 -
$30.92
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.9% below Wall St target ($44.43)
Fair Price Analysis
30-Day Fair Range
$28.61 -
$30.92
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$28.62
Resistance Level
$32.47
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.89
Wall Street Target
$44.43
(+39.9%)
Revenue Growth (YoY)
78.0%
Earnings Growth (YoY)
-6.1%
Profit Margin
72.6%
Valuation Discount vs History
-6.3% cheaper
PE vs Historical
12.9 vs 15.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.3%
(market-implied from PE analysis)
1-Year Target
$29.75
(-6%)
2-Year Target
$27.88
(-12%)
3-Year Target
$26.12
(-18%)
3-Yr Target (if PE normalizes)
(PE: 13→16)
$31.81
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 98.1%)
$186.17
(+486%)
Base:
(SPY PE: 12.9, Growth: 98.1%)
$107.16
(+238%)
Bear:
(PE: 11.0, Growth: 98.1%)
$91.08
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 10.86 | Current EPS (TTM): $2.77
Bull Case
$29.43
(-3%)
Analyst growth -11.1%, PE expands to 12.0
Base Case
$26.75
(-12%)
Market implied -11.1%, PE stable at 10.9
Bear Case
$20.46
(-33%)
Severe decline -20.0%, PE contracts to 9.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.9 to 15.7
Stabilization Target:
$38.66
(+21.8%)
PE Expansion Potential:
+21.8%
Share & Embed Analysis
Last updated: March 30, 2026 2:03 PM ET
Data refreshes hourly during market hours. Next update: 3:03 PM
Data refreshes hourly during market hours. Next update: 3:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TGTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Yann Echelard
SELL
5000 shares
2025-11-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 45 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 57 HOLD |
Advanced TGTX Option Strategies
Professional options setups generated by AI based on today's TGTX price and gamma walls.
